Proposed Collection; 60-Day Comment Request: Federal COVID Response-Audience Feedback To Inform Ongoing Messaging and Strategies for “Combat COVID”, 50143-50144 [2021-19383]

Download as PDF 50143 Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices 2021, times are from 10 a.m. to 4:30 p.m. on November 4th and 10 a.m. to 1:30 p.m. on November 5th. The meeting is closed to the public. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: August 31, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. Proposed Collection; 60-Day Comment Request: Federal COVID Response— Audience Feedback To Inform Ongoing Messaging and Strategies for ‘‘Combat COVID’’ proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. Proposed Collection Title: Federal COVID Response—Audience Feedback to Inform Ongoing Messaging and Strategies for ‘‘Combat COVID,’’ OMB #0925–0769, exp.12/31/2021, EXTENSION, National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of the information collection is to collect routine feedback from the Combat COVID Initiative’s two target audiences (the general public and healthcare providers) to identify evolving needs and better disseminate relevant information as it relates to COVID–19 treatment and ACTIV clinical trial resources, specifically. Data collected will be used to inform the development and broad dissemination of Combat COVID resources, including new or enhanced message and material concepts (e.g., social media ads, digital display ads, out-of-home ads), and/or web pages (combatcovid.hhs.gov). Because the COVID–19 treatment landscape continues to evolve, new evidence-based information continues to come to the forefront, and audience needs continue to change, it is critical for the Federal COVID Response (FCR) Team to collect quick audience feedback from the general public (especially from groups who have not historically been well-represented in clinical trials) and healthcare providers to identify these evolving needs. By understanding target audience needs, the FCR team will be able to properly develop and broadly disseminate relevant COVID–19 treatment and ACTIV clinical trial resources. OMB approval is requested for 1 year. There are no costs to respondents other than their time. The total estimated annualized burden hours are 3,528. National Institutes of Health [FR Doc. 2021–19233 Filed 9–3–21; 8:45 am] BILLING CODE 4140–01–P AGENCY: National Institutes of Health, HHS. DEPARTMENT OF HEALTH AND HUMAN SERVICES ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institutes of Health (NIH), Clinical Center (CC) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. DATES: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. SUMMARY: National Institutes of Health National Institute of Nursing Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research Special Emphasis Panel; Institutional Training Grants. Date: September 24, 2021. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Nursing Research, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ming Yan, MD, Ph.D., Scientific Review Officer, Immunology (IMM), DPPS, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4205, Bethesda, MD 20892, yanming@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: September 2, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–19364 Filed 9–3–21; 8:45 am] BILLING CODE 4140–01–P sradovich on DSKJLST7X2PROD with NOTICES Notice. To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Ms. Mikia P. Currie, Office of Policy for Extramural Research Administration, 6705 Rockledge Drive, Suite 350, Bethesda, Maryland 20892, or call a non-toll free number (301) 435– 0941 or Email your request, including your address to: ProjectClearanceBranch@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. FOR FURTHER INFORMATION CONTACT: Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 requires: written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the SUPPLEMENTARY INFORMATION: ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Consumer Audience Feedback Team Screener ............................................. HCP Audience Feedback Team Screener ...................................................... VerDate Sep<11>2014 00:30 Sep 04, 2021 Jkt 253001 PO 00000 Frm 00132 Fmt 4703 Sfmt 4703 Number of responses per respondent 120 40 U:\07SEN1.SGM 1 1 07SEN1 Average time per response (in hours) 5/60 5/60 Total annual burden hours 10 3 50144 Federal Register / Vol. 86, No. 170 / Tuesday, September 7, 2021 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Type of respondent Average time per response (in hours) Total annual burden hours Consumer Audience Feedback Activity ........................................................... HCP Audience Feedback Activity .................................................................... Benchmark & Follow-Up Web Surveys—Consumer Audience ....................... Benchmark & Follow-Up Web Survey—HCP Audience .................................. 60 20 2,000 300 8 8 5 5 1 1 15/60 15/60 480 160 2,500 375 Total .......................................................................................................... 2,540 12,300 ........................ 3,528 Dated: September 1, 2021. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2021–19383 Filed 9–3–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. sradovich on DSKJLST7X2PROD with NOTICES Number of responses per respondent Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: High Throughput Screening. Date: October 8, 2021. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joseph D Mosca, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5158, MSC 7808, Bethesda, MD 20892, (301) 435– 2344, moscajos@csr.nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group Bioengineering, Technology and Surgical Sciences Study Section. Date: October 12–13, 2021. Time: 8:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 00:30 Sep 04, 2021 Jkt 253001 Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Khalid Masood, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5120, MSC 7854, Bethesda, MD 20892, (301) 435– 2392, masoodk@csr.nih.gov. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Science of Implementation in Health and Healthcare Study Section. Date: October 12–13, 2021. Time: 9:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Wenjuan Wang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3154, Bethesda, MD 20892, (301) 480–8667, wangw22@mail.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Macromolecular Structure and Function A Study Section. Date: October 12–13, 2021. Time: 10:00 a.m. to 9:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: David R Jollie, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4166, MSC 7806, Bethesda, MD 20892, (301) 408– 9072, jollieda@csr.nih.gov. Name of Committee: Applied Immunology and Disease Control Integrated Review Group; Vector Biology Study Section. Date: October 12–13, 2021. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Liangbiao Zheng, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3214, MSC 7808, Bethesda, MD 20892, (301) 402– 5671, zhengli@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; PO 00000 Frm 00133 Fmt 4703 Sfmt 4703 U:\07SEN1.SGM 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: August 31, 2021 Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–19228 Filed 9–3–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel; National Center for Advancing Translational Sciences Special Emphasis Panel. Date: October 7, 2021. Time: 9:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nakia C. Brown, Ph.D., Scientific Review Officer, Office of Grants Management and Scientific Review, National Center for Advancing Translational Sciences, National Institutes of Health, 6701 Democracy Boulevard, Room 1037, Bethesda, 07SEN1

Agencies

[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50143-50144]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-19383]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Proposed Collection; 60-Day Comment Request: Federal COVID 
Response--Audience Feedback To Inform Ongoing Messaging and Strategies 
for ``Combat COVID''

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995 to provide opportunity for public comment on proposed data 
collection projects, the National Institutes of Health (NIH), Clinical 
Center (CC) will publish periodic summaries of proposed projects to be 
submitted to the Office of Management and Budget (OMB) for review and 
approval.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 60 days of the date of 
this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments, submit comments in writing, or 
request more information on the proposed project, contact: Ms. Mikia P. 
Currie, Office of Policy for Extramural Research Administration, 6705 
Rockledge Drive, Suite 350, Bethesda, Maryland 20892, or call a non-
toll free number (301) 435-0941 or Email your request, including your 
address to: [email protected]. Formal requests for 
additional plans and instruments must be requested in writing.

SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995 requires: written comments and/or suggestions 
from the public and affected agencies are invited to address one or 
more of the following points: (1) Whether the proposed collection of 
information is necessary for the proper performance of the function of 
the agency, including whether the information will have practical 
utility; (2) The accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) Ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) Ways 
to minimize the burden of the collection of information on those who 
are to respond, including the use of appropriate automated, electronic, 
mechanical, or other technological collection techniques or other forms 
of information technology.
    Proposed Collection Title: Federal COVID Response--Audience 
Feedback to Inform Ongoing Messaging and Strategies for ``Combat 
COVID,'' OMB #0925-0769, exp.12/31/2021, EXTENSION, National Institutes 
of Health (NIH).
    Need and Use of Information Collection: The purpose of the 
information collection is to collect routine feedback from the Combat 
COVID Initiative's two target audiences (the general public and 
healthcare providers) to identify evolving needs and better disseminate 
relevant information as it relates to COVID-19 treatment and ACTIV 
clinical trial resources, specifically. Data collected will be used to 
inform the development and broad dissemination of Combat COVID 
resources, including new or enhanced message and material concepts 
(e.g., social media ads, digital display ads, out-of-home ads), and/or 
web pages (combatcovid.hhs.gov). Because the COVID-19 treatment 
landscape continues to evolve, new evidence-based information continues 
to come to the forefront, and audience needs continue to change, it is 
critical for the Federal COVID Response (FCR) Team to collect quick 
audience feedback from the general public (especially from groups who 
have not historically been well-represented in clinical trials) and 
healthcare providers to identify these evolving needs. By understanding 
target audience needs, the FCR team will be able to properly develop 
and broadly disseminate relevant COVID-19 treatment and ACTIV clinical 
trial resources.
    OMB approval is requested for 1 year. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 3,528.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)     burden hours
----------------------------------------------------------------------------------------------------------------
Consumer Audience Feedback Team Screener........             120               1            5/60              10
HCP Audience Feedback Team Screener.............              40               1            5/60               3

[[Page 50144]]

 
Consumer Audience Feedback Activity.............              60               8               1             480
HCP Audience Feedback Activity..................              20               8               1             160
Benchmark & Follow-Up Web Surveys--Consumer                2,000               5           15/60           2,500
 Audience.......................................
Benchmark & Follow-Up Web Survey--HCP Audience..             300               5           15/60             375
                                                 ---------------------------------------------------------------
    Total.......................................           2,540          12,300  ..............           3,528
----------------------------------------------------------------------------------------------------------------


    Dated: September 1, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-19383 Filed 9-3-21; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.